D'Anna Lucio, Foschi Matteo, Russo Michele, Dolkar Tsering, Vittay Orsolya, Dixon Luke, Bentley Paul, Brown Zoe, Hall Charles, Halse Omid, Jamil Sohaa, Jenkins Harri, Kalladka Dheeraj, Kwan Joseph, Malik Abid, Patel Maneesh, Rane Neil, Roi Dylan, Singh Abhinav, Venter Marius, Lobotesis Kyriakos, Banerjee Soma
Department of Stroke and Neuroscience, Charing Cross Hospital, Imperial College London NHS Healthcare Trust, London W6 8RF, UK.
Department of Brain Sciences, Imperial College London, London SW7 2AZ, UK.
J Clin Med. 2023 Feb 1;12(3):1150. doi: 10.3390/jcm12031150.
Mechanical thrombectomy (MT) is the standard of care for eligible patients with a large vessel occlusion (LVO) acute ischemic stroke. Among patients undergoing MT there has been uncertainty regarding the role of intravenous thrombolysis (IVT) and previous trials have yielded conflicting results regarding clinical outcomes. We aim to investigate clinical, reperfusion outcomes and safety of MT with or without IVT for ischemic stroke due to anterior circulation LVO. This observational, prospective, single-centre study included consecutive patients with acute LVO ischemic stroke of the anterior circulation. The primary outcomes were the rate of in-hospital mortality, symptomatic intracranial haemorrhage and functional independence (mRS 0-2 at 90 days). We enrolled a total of 577 consecutive patients: 161 (27.9%) were treated with MT alone while 416 (72.1%) underwent IVT and MT. Patients with MT who were treated with IVT had lower rates of in-hospital mortality ( = 0.037), higher TICI reperfusion grades ( = 0.007), similar rates of symptomatic intracranial haemorrhage ( = 0.317) and a higher percentage of functional independence mRS (0-2) at 90 days ( = 0.022). Bridging IVT with MT compared to MT alone was independently associated with a favorable post-intervention TICI score (>2b) (OR, 1.716; 95% CI, 1.076-2.735, = 0.023). Our findings suggest that combined treatment with MT and IVT is safe and results in increased reperfusion rates as compared to MT alone.
机械取栓术(MT)是符合条件的大血管闭塞(LVO)急性缺血性卒中患者的标准治疗方法。在接受MT治疗的患者中,静脉溶栓(IVT)的作用一直存在不确定性,以往的试验在临床结局方面产生了相互矛盾的结果。我们旨在研究MT联合或不联合IVT治疗前循环LVO所致缺血性卒中的临床、再灌注结局及安全性。这项观察性、前瞻性、单中心研究纳入了连续性前循环急性LVO缺血性卒中患者。主要结局指标为住院死亡率、症状性颅内出血发生率和功能独立性(90天时改良Rankin量表评分0 - 2分)。我们共纳入了577例连续性患者:161例(27.9%)仅接受MT治疗,416例(72.1%)接受IVT联合MT治疗。接受IVT联合MT治疗的患者住院死亡率较低(P = 0.037),脑梗死溶栓分级(TICI)再灌注等级较高(P = 0.007),症状性颅内出血发生率相似(P = 0.317),90天时功能独立性改良Rankin量表评分(0 - 2分)的比例更高(P = 0.022)。与单纯MT相比,IVT联合MT独立与干预后TICI评分>2b相关(比值比,1.716;95%置信区间,1.076 - 2.735,P = 0.023)。我们的研究结果表明,与单纯MT相比,MT联合IVT治疗是安全的,且再灌注率更高。